HUMULIN-N (NPH) ACTRAPID HM INSULATARD-HM HUMULIN-ULTRA LENTE ZANSULIN NPH ZANSULIN REGULAR ZANSULIN INSULATARD NOVOLET ACTRAPID NOVOLET MIXTARD 30 NOVOLET NOVOPEN 3 ACTRAPID PENFILL INSULATARD PENFILLS PEN NEEDLES INSUGET R DONGSULIN N DONGSULIN N INSUGET 70/30 ACTRAPID ® INNOLET ® INSULATARD ® INNOLET ® MIXTARD 30 INNOLET INSUMAN RAPID JUSLINE REGULAR

Dose: 0.05 to 0.2 IU/ kg
Single Dose: 0.12 (0.125)
Frequency: 12 hourly
Route: IV
Instructions: Dose depends upon blood sugar level

Dose: 0.25 to 0.5 IU/kg
Single Dose: 0.38 (0.375)
Frequency: 24 hourly
Route: Subcutaneous
Instructions:

Dose: 0.25 to 0.5 IU/kg
Single Dose: 0.38 (0.375)
Frequency: 24 hourly
Route: Subcutaneous
Instructions: -

Human Insulin also known as . . It is of Natural origin and belongs to Polypeptide. It belongs to Insulin agonist pharmacological group on the basis of mechanism of action and also classified in Antidiabetic Agent, Insulin pharmacological group.The Molecular Weight of Human Insulin is 5777.60.

Human Insulin

Human Insulin produces potentially life-threatening effects which include Hypoglycemia, Hypoglycemia, Hypoglycemia. which are responsible for the discontinuation of Human Insulin therapy.

Human Insulin is primarily indicated in conditions like Diabetes mellitus, Hyperkalaemia, Iddm.

Human Insulin is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementAdrenalineAlcoholAmitriptyline (HCl)AspirinCaptoprilACE inhibitors (e.g Captopril) possibly enhance hypoglycemic effect of insulin. Chlordiazepoxide (HCl)Chlorpromazine (HCl)Clonidine (HCl)CyclophosphamideDanazoldanzaol increase insulin resistancepatient should be carefully monitoredDiazoxideDiltiazem (HCl)DisopyramideFenfluramine (HCl)GestodeneGuanethidineIsoniazidLithiumLynoestrenolMebendazoleNadololNifedipineOctreotide (Acetate)Troglitazone These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Drug should not be given to patients suffering from Kidney dysfunction.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Inj Store at room temperature, Below 15°C or in refrigerator. Do not Freeze. Protect from Sunlight. Use within 2 years(at 4C) if refrigerated and within 1 month if kept at room temperature.

its doses will vary among patients and should be determined by the healthcare provider familiar with the patient€™s metabolic needs, eating habits, and other lifestyle variablesThe dose of insulin lispro protamine when available in combination with insulin lispro (75/25 or 50/50 ratio) should be given within 15 minutes before a meal.